Abstract: The present application relates to a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, as well as to pharmaceutical compositions comprising same. The use of such compounds, pharmaceutically acceptable salts thereof or pharmaceutical compositions for inhibiting the activity of an IL-I receptor in a cell, or for treating IL-1 related diseases, disorders or conditions such as inflammatory diseases in a subject, is also described.